Efficacy and safety of baricitinib for the treatment of moderate-to-severe atopic dermatitis: A systematic review and meta-analysis of randomized clinical trials

被引：3

作者：

Wang, Bin ^{[1
]}

Pan, Shuaixi ^{[2
]}

Yao, Yue ^{[1
]}

Zeng, Linxi ^{[1
]}

Zhang, Guoqiang ^{[1
,3
]}

机构：

[1] Hebei Med Univ, Hosp 1, Dept Dermatol, 89 Donggang Rd, Shijiazhuang, Hebei, Peoples R China

[2] Hebei Med Univ, Dept Optometry, Shijiazhuang, Hebei, Peoples R China

[3] Natl Clin Res Ctr Skin Dis, Candidate Branch, Shijiazhuang, Hebei, Peoples R China

来源：

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | 2022年 / 49卷 / 11期

关键词：

atopic dermatitis; baricitinib; Janus kinase inhibitor; MANAGEMENT; DUPILUMAB;

D O I：

10.1111/1440-1681.13704

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Atopic dermatitis (AD) is one of the most prevalent inflammatory skin diseases. Janus kinase (JAK) inhibitor baricitinib is a promising treatment for AD as shown in recent clinical trials. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) reporting the efficacy and safety of baricitinib. Data analysis was carried out using Cochrane Collaboration Review Manager 5.4 software and performed as risk ratios (RR) with 95% confidence intervals. Six RCTs involving a total of 2595 patients were included in the review. The meta-analysis revealed that patients in the baricitinib group had significantly higher rates achieving EASI75, EASI90, IGA-Response, SCORAD75, and Itch NRS improvement. Pooled analysis also showed no significant differences in treatment of emergent adverse events (TEAEs) between baricitinib and placebo groups. In conclusion, our meta-analysis showed that baricitinib has promising efficacy for moderate-to-severe AD with favourable safety files.

引用

页码：1139 / 1149

页数：11

共 33 条

[1] Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials [J].

Bieber, T. ;

Thyssen, J. P. ;

Reich, K. ;

Simpson, E. L. ;

Katoh, N. ;

Torrelo, A. ;

De Bruin-Weller, M. ;

Thaci, D. ;

Bissonnette, R. ;

Gooderham, M. ;

Weisman, J. ;

Nunes, F. ;

Brinker, D. ;

Issa, M. ;

Holzwarth, K. ;

Gamalo, M. ;

Riedl, E. ;

Janes, J. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (02) :476-485

[2] Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial [J].

Blauvelt, Andrew ;

de Bruin-Weller, Marjolein ;

Gooderham, Melinda ;

Cather, Jennifer C. ;

Weisman, Jamie ;

Pariser, David ;

Simpson, Eric L. ;

Papp, Kim A. ;

Hong, H. Chih-Ho ;

Rubel, Diana ;

Foley, Peter ;

Prens, Errol ;

Griffiths, Christopher E. M. ;

Etoh, Takafumi ;

Pinto, Pedro Herranz ;

Pujol, Ramon M. ;

Szepietowski, Jacek C. ;

Ettler, Karel ;

Kemeny, Lajos ;

Zhu, Xiaoping ;

Akinlade, Bolanle ;

Hultsch, Thomas ;

Mastey, Vera ;

Gadkari, Abhijit ;

Eckert, Laurent ;

Amin, Nikhil ;

Graham, Neil M. H. ;

Pirozzi, Gianluca ;

Stahl, Neil ;

Yancopoulos, George D. ;

Shumel, Brad .

LANCET, 2017, 389 (10086) :2287-2303

[3] JAK inhibitors in the treatment of atopic dermatitis [J].

Chovatiya, Raj ;

Paller, Amy S. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 148 (04) :927-940

[4] Guidelines of care for the management of atopic dermatitis Section 1. Diagnosis and assessment of atopic dermatitis [J].

Eichenfield, Lawrence F. ;

Tom, Wynnis L. ;

Chamlin, Sarah L. ;

Feldman, Steven R. ;

Hanifin, Jon M. ;

Simpson, Eric L. ;

Berger, Timothy G. ;

Bergman, James N. ;

Cohen, David E. ;

Cooper, Kevin D. ;

Cordoro, Kelly M. ;

Davis, Dawn M. ;

Krol, Alfons ;

Margolis, David J. ;

Paller, Amy S. ;

Schwarzenberger, Kathryn ;

Silverman, Robert A. ;

Williams, Hywel C. ;

Elmets, Craig A. ;

Block, Julie ;

Harrod, Christopher G. ;

Begolka, Wendy Smith ;

Sidbury, Robert .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (02) :338-351

[5] Update on Atopic Dermatitis: Diagnosis, Severity Assessment, and Treatment Selection [J].

Fishbein, Anna B. ;

Silverberg, Jonathan I. ;

Wilson, Eve J. ;

Ong, Peck Y. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (01) :91-101

[6] A systematic review of Investigator Global Assessment (IGA) in atopic dermatitis (AD) trials: Many options, no standards [J].

Futamura, Masaki ;

Leshem, Yael A. ;

Thomas, Kim S. ;

Nankervis, Helen ;

Williams, Hywel C. ;

Simpson, Eric L. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (02) :288-294

[7] Dupilumab: A review of its use in the treatment of atopic dermatitis [J].

Gooderham, Melinda J. ;

Hong, H. Chih-ho ;

Eshtiaghi, Panteha ;

Papp, Kim A. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (03) :S28-S36

[8] Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study [J].

Guttman-Yassky, Emma ;

Silverberg, Jonathan I. ;

Nemoto, Osamu ;

Forman, Seth B. ;

Wilke, August ;

Prescilla, Randy ;

de la Pena, Amparo ;

Nunes, Fabio P. ;

Janes, Jonathan ;

Gamalo, Margaret ;

Donley, David ;

Paik, Jim ;

DeLozier, Amy M. ;

Nickoloff, Brian J. ;

Simpson, Eric L. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (04) :913-+

[9] Cytokine modulation of atopic dermatitis filaggrin skin expression [J].

Howell, Michael D. ;

Kim, Byung Eui ;

Gao, Peisong ;

Grant, Audrey V. ;

Boguniewicz, Mark ;

DeBenedetto, Anna ;

Schneider, Lynda ;

Beck, Lisa A. ;

Barnes, Kathleen C. ;

Leung, Donald Y. M. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (01) :150-155

[10] Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 [J].

Kalil, A. C. ;

Patterson, T. F. ;

Mehta, A. K. ;

Tomashek, K. M. ;

Wolfe, C. R. ;

Ghazaryan, V. ;

Marconi, V. C. ;

Ruiz-Palacios, G. M. ;

Hsieh, L. ;

Kline, S. ;

Tapson, V. ;

Iovine, N. M. ;

Jain, M. K. ;

Sweeney, D. A. ;

El Sahly, H. M. ;

Branche, A. R. ;

Pineda, J. Regalado ;

Lye, D. C. ;

Sandkovsky, U. ;

Luetkemeyer, A. F. ;

Cohen, S. H. ;

Finberg, R. W. ;

Jackson, P. E. H. ;

Taiwo, B. ;

Paules, C. I. ;

Arguinchona, H. ;

Erdmann, N. ;

Ahuja, N. ;

Frank, M. ;

Oh, M. ;

Kim, E. -S. ;

Tan, S. Y. ;

Mularski, R. A. ;

Nielsen, H. ;

Ponce, P. O. ;

Taylor, B. S. ;

Larson, L. A. ;

Rouphael, N. G. ;

Saklawi, Y. ;

Cantos, V. D. ;

Ko, E. R. ;

Engemann, J. J. ;

Amin, A. N. ;

Watanabe, M. ;

Billings, J. ;

Elie, M. -C. ;

Davey, R. T. ;

Burgess, T. H. ;

Ferreira, J. ;

Green, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (09) :795-807

← 1 2 3 4 →